-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Exagen, Lowers Price Target to $10

Benzinga·03/11/2026 15:09:08
Listen to the news
Craig-Hallum analyst John Wilkin maintains Exagen (NASDAQ:XGN) with a Buy and lowers the price target from $12 to $10.